| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
78.48(M) |
| Last
Volume: |
667,553 |
Avg
Vol: |
3,188,039 |
| 52
Week Range: |
$0.131 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dembow George F |
Director |
– • – |
2008-06-02 |
4 |
S |
$0.99 |
$4,950 |
D/D |
(5,000) |
390,000 |
|
- |
|
| Dembow George F |
Director |
– • – |
2008-05-19 |
4 |
S |
$0.50 |
$2,500 |
D/D |
(5,000) |
395,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2008-05-05 |
5 |
S |
$0.65 |
$618 |
I/I |
(950) |
264,474 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2008-02-21 |
5 |
GD |
$0.00 |
$0 |
D/D |
170,000 |
1,119,071 |
|
- |
|
| Allen Allen D |
Chief Executive Officer |
• • • |
2007-08-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
120,000 |
1,761,415 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-08-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
270,000 |
1,305,521 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-06-22 |
4 |
B |
$0.60 |
$1,250 |
D/D |
2,000 |
1,575,521 |
3.15 |
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-06-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
105,000 |
1,573,521 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-06-20 |
4 |
GA |
$0.00 |
$0 |
D/D |
250,000 |
1,678,521 |
|
- |
|
| Allen Allen D |
Chief Executive Officer |
• • • |
2007-06-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
250,000 |
1,881,415 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-05-21 |
4 |
B |
$0.55 |
$1,375 |
D/D |
2,500 |
1,428,521 |
3.15 |
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
170,000 |
1,426,021 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-05-17 |
4 |
A |
$0.60 |
$1,560 |
D/D |
2,600 |
1,596,021 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
1,593,421 |
|
- |
|
| Allen Allen D |
Chief Executive Officer |
• • • |
2007-02-22 |
4 |
A |
$0.75 |
$5,925 |
D/D |
7,900 |
2,131,415 |
|
- |
|
| Utek Corp |
10% Owner |
– – • |
2007-01-30 |
4 |
B |
$8.45 |
$845,000 |
D/D |
100,000 |
100,000 |
2.45 |
- |
|
| Allen Corrine |
Vice President |
• • • |
2007-01-09 |
4 |
A |
$0.75 |
$5,850 |
D/D |
7,800 |
1,611,871 |
|
- |
|
| Utek Corp |
10% Owner |
– – • |
2006-07-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,040,000 |
|
- |
|
| Leong Jonathan R |
Director |
– • – |
2006-05-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,000 |
|
- |
|
| Gould Gregory A |
Director |
– • – |
2006-03-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2005-12-07 |
4 |
A |
$1.95 |
$3,023 |
D/D |
1,550 |
1,613,421 |
|
- |
|
| Allen Corrine |
Vice President |
• • • |
2005-09-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
132,264 |
1,604,071 |
|
- |
|
| Allen Allen D |
Chief Executive OfficerOfficer |
• • • |
2003-10-28 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,123,515 |
|
- |
|
| Mcmahon Brian J |
Executive Vice PresidentOffice |
• – – |
2003-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,614 |
|
- |
|
| Strickland Daniel M |
Director |
– • – |
2003-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,476 |
|
- |
|
381 Records found
|
|
Page 15 of 16 |
|
|
